The crystal structure of the cocrystal 4-hydroxy-3,5-dimethoxybenzoic acid–pyrazine-2-carboxamide(1/1), C14H15N3O6-Reference-Cited by-同舟云学术

The crystal structure of the cocrystal 4-hydroxy-3,5-dimethoxybenzoic acid–pyrazine-2-carboxamide(1/1), C₁₄H₁₅N₃O₆

Published:2022-07-14 Issue:5 Volume:237 Page:845-847
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Jiang Cheng-Jun¹^ORCID,Xia Ying-Fan¹^ORCID,Xie Yan-Song²

Affiliation:

1. School of Biological and Chemical Engineering , Zhejiang University of Science and Technology , Hangzhou , Liuhe Road 318# , China

2. Shanghai Pharma Resources (Shanghai) Co., Ltd. , Building A, Building 9, No. 528, Ruiqing Road, Heqing Town, Pudong New District , Shanghai , China

Abstract

Abstract C14H15N3O6, monoclinic, C2/c (no. 15), a = 30.1620(13) Å, b = 3.8559(2) Å, c = 27.3897(13) Å, β = 117.610(4)°, V = 2822.7(3) Å3, Z = 8, Rgt (F) = 0.0332, wRref (F 2) = 0.0904, T = 170 K.

Publisher

Walter de Gruyter GmbH

Subject

Inorganic Chemistry,Condensed Matter Physics,General Materials Science

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2022-0288/pdf

Reference9 articles.

1. Bruker. APEX3 v. 2016.9?0 and SAINT v. 8.37A; Bruker Axs Inc.: Madison, Wisconsin, USA, 2016.

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.

3. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.

4. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.

5. Rajendran, M. A., Allada, R., Sajid, S. S. Co-crystals for generic pharmaceuticals: an outlook on solid oral dosage formulations. Recent Adv. Drug Deliv. Formulation 2021, 15, 15–36; https://doi.org/10.2174/2667387815666210203151209.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinatorial Effect of Syringic Acid-Pyrazinamide Adduct against Luminal Type Breast Cancer Investigated through DFT, Drug-Likeness, and Molecular Docking Simulation;Polycyclic Aromatic Compounds;2023-05-21